Table: begin end state 1 20 cytoplasmic 21 51 transmembrane 52 56 non-cytoplasmic 57 81 transmembrane 82 93 cytoplasmic 94 117 transmembrane 118 126 non-cytoplasmic 127 148 transmembrane 149 160 cytoplasmic 161 180 transmembrane 181 191 non-cytoplasmic 192 211 transmembrane 212 241 cytoplasmic 242 262 transmembrane 263 273 non-cytoplasmic 274 295 transmembrane 296 306 cytoplasmic 307 326 transmembrane 327 331 non-cytoplasmic 332 356 transmembrane 357 369 cytoplasmic 370 393 transmembrane 394 401 non-cytoplasmic 402 420 transmembrane 421 427 cytoplasmic
Input: >BPHYT_RS08740 FitnessBrowser__BFirm:BPHYT_RS08740 MSTSTLQASAARPSAAKVHRIILAASIGNALEWFDLVVYGFFAVTIAKLFFPARTEAISL MLTLGTFGISYMIRPLGGLVLGSLADRAGRKASLLLSIALMMVGTLTIAVMPPYAAIGLW APAGIMLSRLVQGFSAGGEFGASTAFLVEHAPERRGFMGSWQFASQGMATLLASGFGALL TSQLTSAQLESWGWRVPFLFGLAIGPVGFYIRRYVDEGAEFNAEPKARTPLRDLFGTQKV RMLLAVGSLIISTAANYMILYMPTYAIKQLHLPASTGFAATLATGVVLTVLTPFAGHLSD RLGRIRIMATAAVLMLVTVYPAFVYMNAHPSFVTMLLALIWIGVLKATYFGALPALMSEI FPTQTRATGLAVSYNIGVTVFGGFAPFVITWLIDASGNKLAPGFYLMFCAVASLLALYAV RGRLKIR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server